Biogen to buy Apellis Pharmaceuticals for $5.6 billion

Biogen to buy Apellis Pharmaceuticals for $5.6 billion | ReutersExclusive news, data and analytics for financial market professionalsLearn more aboutRefinitivA test tube is seen in front of displayed Biogen logo in this illustration taken, December 1, 2021. REUTERS/Dado Ruvic/Illustration Purchase Licensing Rights, opens new tabCompaniesApellis Pharmaceuticals IncFollowBiogen IncFollowMarch 31 (Reuters) - Biogen (BIIB.O), opens new tabsaid on Tuesday it has agreed to acquire Apellis Pharmaceu ...